中国药物警戒 ›› 2014, Vol. 11 ›› Issue (6): 336-339.

• 政策与法规研究 • 上一篇    下一篇

基于KMRW声誉模型的药品生产企业诚信规范研究

傅议娇, 武志昂*   

  1. 沈阳药科大学工商管理学院,辽宁 沈阳 110016
  • 收稿日期:2014-01-06 修回日期:2016-02-03 出版日期:2014-06-08 发布日期:2016-03-02
  • 通讯作者: 武志昂,男,教授,博士生导师,药品风险管理。
  • 作者简介:傅议娇,女,在读硕士,药事管理。

Drug Quality Problem Analysis Based on KMRW Model

FU Yi-jiao, WU Zhi-ang*   

  1. College of Administration, Shenyang Pharmaceutical University, Liaoning Shenyang 110016, China
  • Received:2014-01-06 Revised:2016-02-03 Online:2014-06-08 Published:2016-03-02

PDF (PC)

299

摘要： 目的通过利用声誉理论对现行质量监管体制下药品生产企业的质量选择行为进行分析,提出影响企业诚信经营的关键点,为促进我国药品生产企业诚信规范提供参考。方法基于声誉理论的KMRW模型,对我国药品生产企业机会主义行为进行理论分析,得出企业实施机会主义行为的关键因素。结果与结论 不完全信息条件下,药品生产企业有采取机会主义行为的倾向,而声誉的信号显示效应可以抑制机会主义行为,促使企业维护良好声誉,从而提高产品质量。

关键词: 药品质量安全, KMRW模型, 机会主义行为

Abstract: Objective The reputation theory in production of pharmaceutical manufacturers was used to identify the key factors that affect manufacturers integrity, in order to provide references to promote the integrity of our specification of phar-maceutical manufacturers. MethodsThe opportunistic behavior of pharmaceutical manufacturers was analyzed theoretically based on KMWR model of reputation theory, and identified the key factors that manufacturers implement the opportunistic behavior. Resultsand ConclusionUnder the conditions of incomplete information,pharmaceutical manufacturers have a tendency to take opportunistic behavior, and the signal display effect of reputation can inhibit the opportunistic behavior, and encourage manufacturers to maintain a good reputation, thereby improving product quality.

Key words: drug quality safety, KMRW model, opportunistic behavior

中图分类号: